KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) Equity Average: 2009-2024

Historic Equity Average for Dynavax Technologies (DVAX) over the last 16 years, with Dec 2024 value amounting to $609.4 million.

  • Dynavax Technologies' Equity Average fell 22.35% to $514.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $514.1 million, marking a year-over-year decrease of 22.35%. This contributed to the annual value of $609.4 million for FY2024, which is 1.31% up from last year.
  • Latest data reveals that Dynavax Technologies reported Equity Average of $609.4 million as of FY2024, which was up 1.31% from $601.5 million recorded in FY2023.
  • Dynavax Technologies' 5-year Equity Average high stood at $609.4 million for FY2024, and its period low was $33.5 million during FY2020.
  • In the last 3 years, Dynavax Technologies' Equity Average had a median value of $601.5 million in 2023 and averaged $537.6 million.
  • In the last 5 years, Dynavax Technologies' Equity Average fell by 6.13% in 2020 and then spiked by 319.61% in 2021.
  • Dynavax Technologies' Equity Average (Yearly) stood at $33.5 million in 2020, then spiked by 319.61% to $140.5 million in 2021, then surged by 185.83% to $401.7 million in 2022, then spiked by 49.75% to $601.5 million in 2023, then increased by 1.31% to $609.4 million in 2024.